triamcinolone
Facts
16 properties- Instance of
- type of chemical entity
- Subclass of
- 9-fluoro-11,16,17-trihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one
- Has use
- medication
- Active ingredient in
- Nasacort, Aristospan, Kenalog, AllerNaze, Oralone, Pediaderm TA, Trianex, Dermasorb TA, Triesence, Triderm
- Canonical SMILES
- CC12CC(C3(C(C1CC(C2(C(=O)CO)O)O)CCC4=CC(=O)C=CC43C)F)O
- Chemical formula
- C₂₁H₂₇FO₆
- Defined daily dose
- 0.22 mg
- Has part(s)
- carbon
- Isomeric SMILES
- C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O
- Mass
- 394.179 Da
- Medical condition treated
- inflammation, systemic lupus erythematosus, enthesopathy, leg dermatosis, hand dermatosis, facial dermatosis, scalp dermatosis, hypersensitivity, osteoarthritis susceptibility 1, keloid, cystoid macular edema, macular retinal edema
- Physically interacts with
- Nuclear receptor subfamily 3 group C member 1, Glucocorticoid receptor
- Pregnancy category
- Australian pregnancy category A, US pregnancy category C
- Significant drug interaction
- hydrochlorothiazide, moxifloxacin, aspirin, ritonavir, rac-warfarin, acenocoumarol, rocuronium, atracurium, cisatracurium
- Subject has role
- 5-lipoxygenase inhibitor, selective glucocorticoid receptor agonist, anti-inflammatory agent, glucocorticoid
- World Health Organisation international non-proprietary name
- triamcinolone
- Library of Congress Authorities ID
- sh85137404
- BVPB authority ID
- 110384
- CAS Registry Number
- 124-94-7
- ChEBI ID
- 9667
- ChEMBL ID
- CHEMBL1451
- ChemSpider ID
- 29046
- DSSTOX compound identifier
- DTXCID9020742
- DSSTox substance ID
- DTXSID1040742
- DrugBank ID
- DB00620
- DrugCentral ID
- 2725
- EC number
- 204-718-7
Show all 48 identifiers +36
- ECHA Substance Infocard ID
- 100.004.290
- Elhuyar ZTH ID
- 031383
- Freebase ID
- /m/04ld6k
- Gran Enciclopèdia Catalana ID
- triamcinolona
- Gran Enciclopèdia Catalana ID (former scheme)
- 0148049
- Guide to Pharmacology Ligand ID
- 2870
- HSDB ID
- 3194
- Human Metabolome Database ID
- HMDB0014758
- InChIKey
- GFNANZIMVAIWHM-OBYCQNJPSA-N
- KBpedia ID
- Triamcinolone
- KEGG ID
- D00385
- LEM ID
- LEM201008995
- MassBank accession ID
- MSBNK-Athens_Univ-AU240057, MSBNK-Athens_Univ-AU240058, MSBNK-Athens_Univ-AU240059, MSBNK-Athens_Univ-AU240060
- MeSH concept ID
- M0021894
- MeSH descriptor ID
- D014221
- MeSH tree code
- D04.210.500.745.432.915, D04.210.500.908.891
- Microsoft Academic ID (discontinued)
- 2779473686
- NALT ID
- 10159
- NDF-RT ID
- N0000145980
- Probes And Drugs ID
- PD002598
- PubChem CID
- 31307
- Quora topic ID
- Triamcinolone
- Reaxys registry number
- 2341955
- RxNorm CUI
- 10759
- SureChEMBL ID
- 4447
- UMLS CUI
- C0040864
- UNII
- 1ZK20VI6TY
- UniChem compound ID
- 204584
- Wellcome Collection concept ID
- gtc8zsh9
- WikiProjectMed ID
- Triamcinolone
- WordNet 3.1 Synset ID
- 15103335-n
- Yale LUX ID
- concept/5d047ba3-fe99-461c-98af-7cb66900a961
Significant drug interaction 10
← Significant drug interaction 10
← Drug or therapy used for treatment 7
Medical condition treated 6
Subject has role 2
Has part(s) 1
Has use 1
0 sources
Summary
triamcinolone is a type of chemical entity[1]. triamcinolone is a type of 9-fluoro-11,16,17-trihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one[2].
Key Facts
- Physically interacts with: Nuclear receptor subfamily 3 group C member 1[3], Glucocorticoid receptor[4]
- Canonical SMILES: CC12CC(C3(C(C1CC(C2(C(=O)CO)O)O)CCC4=CC(=O)C=CC43C)F)O[5]
- Chemical formula: C₂₁H₂₇FO₆[6]
- Has use: medication[7]
- Has part(s): carbon[8]
- Significant drug interaction: hydrochlorothiazide[9], moxifloxacin[10], aspirin[11], ritonavir[12], rac-warfarin[13], acenocoumarol[14], rocuronium[15], atracurium[16], cisatracurium[17]
- Isomeric SMILES: C[C@]12CC@@HOC@@HO">[18]
- Mass: 394.179 dalton[19]
- Medical condition treated: inflammation[20], systemic lupus erythematosus[21], enthesopathy[22], leg dermatosis[23], hand dermatosis[24], facial dermatosis[25], scalp dermatosis[26], hypersensitivity[27], osteoarthritis susceptibility 1[28], keloid[29], cystoid macular edema[30], macular retinal edema[31]
- World Health Organisation international non-proprietary name: triamcinolone[32]
- Subject has role: 5-lipoxygenase inhibitor[33], selective glucocorticoid receptor agonist[34], anti-inflammatory agent[35]